keyword
https://read.qxmd.com/read/38625582/prevention-and-treatment-of-ischaemic-and-haemorrhagic-stroke-in-people-with-diabetes-mellitus-a-focus-on-glucose-control-and-comorbidities
#21
REVIEW
Simona Sacco, Matteo Foschi, Raffaele Ornello, Federico De Santis, Riccardo Pofi, Michele Romoli
Diabetes mellitus is a significant risk factor for both ischaemic and haemorrhagic stroke, affecting up to a third of individuals with cerebrovascular diseases. Beyond being a risk factor for stroke, diabetes and hyperglycaemia have a negative impact on outcomes after ischaemic and haemorrhagic stroke. Hyperglycaemia during the acute ischaemic stroke phase is associated with a higher risk of haemorrhagic transformation and poor functional outcome, with evidence in favour of early intervention to limit and manage severe hyperglycaemia...
April 16, 2024: Diabetologia
https://read.qxmd.com/read/38623532/attenuation-of-bone-mineral-density-decline-during-anemia-treatment-with-methenolone-acetate-in-myelodysplastic-syndrome
#22
Shu Ushimaru, Hirofumi Sumi, Mea Aso, Rie Fujishima, Kazuhiro Shiizaki, Naoto Tominaga
In an aging society, addressing the risks and management of osteoporotic fractures is critical to reduce mortality. Similarly, the morbidity of chronic kidney disease and myelodysplastic syndrome increases with aging. The association between chronic kidney disease and fractures is well understood; however, recent reports have indicated an increased risk of incident osteoporosis in patients with prevalent myelodysplastic syndrome. In this case report, we present an older man with stage 4 chronic kidney disease complicated by myelodysplastic syndrome and progressive decline in bone mineral density...
April 2024: JCEM Case Rep
https://read.qxmd.com/read/38623097/elizabethkingia-meningoseptica-causing-infection-in-a-chronic-kidney-disease-patient-with-hepatitis-b-positive-status-unraveling-the-hidden-culprit
#23
Gautam N Bedi, Sourya Acharya, Smruti A Mapari, Pranjal Kashiv, Sushrut Gupta
Elizabethkingia meningoseptica is a rare gram-negative bacterium recognized for its propensity to induce hospital-acquired infections, particularly in individuals with compromised immune systems and those equipped with indwelling medical devices. Its notorious resistance to a broad spectrum of antibiotics poses a considerable challenge in treatment protocols, contributing to its emergence as a significant cause of heightened mortality rates among critically ill patients. Herein, we present a case of E. meningoseptica infection in a patient afflicted with end-stage renal disease (ESRD) undergoing maintenance hemodialysis, concurrently grappling with ESRD, and a positive status for hepatitis B...
March 2024: Curēus
https://read.qxmd.com/read/38622007/mental-health-and-quality-of-life-in-chronic-kidney-disease-patients-with-mild-to-moderate-depression-a-retrospective-cohort-study-of-mindfulness-based-stress-reduction-therapy
#24
JOURNAL ARTICLE
Xiumei Li, Wei Gao, Jie Yu, Yanling Mao, Haihong Gu, Fang Li, Dongmei Ren
BACKGROUND: Chronic kidney disease (CKD) patients may experience pessimism, and even despair, due to long-term nature of the condition, which increases the risk of depression. Mindfulness-based stress reduction (MBSR) can relieve depression. This retrospective cohort study aimed to investigate the effects of MBSR on mental health and quality of life in CKD patients with mild-to-moderate depression, so as to provide guidance for clinical nursing programs. METHODS: The clinical data of 100 CKD patients with mild-to-moderate depression who were treated in Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences from January 2021 to March 2023 were retrospectively analyzed...
April 2024: Actas Españolas de Psiquiatría
https://read.qxmd.com/read/38621632/erythrocytosis-and-ckd
#25
REVIEW
Mabel Aoun, Michel Jadoul, Hans-Joachim Anders
Erythrocytosis or polycythemia is defined as an increase in red blood cell concentration above the age- and sex-specific normal levels. Unlike anemia that is very common in chronic kidney disease (CKD) patients, erythrocytosis is less frequent but requires specific understanding by healthcare professionals in order to provide the best care. Erythrocytosis, especially when undiagnosed and untreated, can lead to serious thrombotic events and higher mortality. Classical causes of erythrocytosis associated with CKD include cystic kidney diseases, kidney or other erythropoietin-secreting neoplasms, high-altitude renal syndrome, overdosage of erythropoietin-stimulating agents, androgen therapy, heavy smoking, chronic lung disease, obstructive sleep apnea, IgA nephropathy, post-kidney transplant erythrocytosis, renal artery stenosis and congenital etiologies...
April 13, 2024: American Journal of Kidney Diseases
https://read.qxmd.com/read/38621435/unlocking-the-potential-of-brewers-spent-grain-a-sustainable-model-to-use-beer-for-better-outcome-in-chronic-kidney-disease
#26
REVIEW
Babak Ghajavand, Carla Avesani, Peter Stenvinkel, Annette Bruchfeld
The rising global incidence of chronic inflammatory diseases calls for innovative and sustainable medical solutions. Brewers' spent grain (BSG), a byproduct of beer production, presents a unique opportunity in this regard. This review explores the multifaceted health benefits of BSG, with a focus on managing chronic kidney disease (CKD). BSG is identified as a potent prebiotic with potential as a therapeutic agent in CKD. We emphasize the role of gut dysbiosis in CKD and discuss how BSG could help mitigate metabolic derangements resulting from dysbiosis and CKD...
April 13, 2024: Journal of Renal Nutrition
https://read.qxmd.com/read/38621432/associations-between-dietary-potassium-intake-from-different-food-sources-and-hyperkalemia-in-patients-with-chronic-kidney-disease
#27
JOURNAL ARTICLE
Nobuhisa Morimoto, Shingo Shioji, Yuichiro Akagi, Tamami Fujiki, Shintaro Mandai, Fumiaki Ando, Takayasu Mori, Koichiro Susa, Shotaro Naito, Eisei Sohara, Tatsuhiko Anzai, Kunihiko Takahashi, Wataru Akita, Akihito Ohta, Shinichi Uchida, Soichiro Iimori
OBJECTIVE: Previous studies reported mixed results on associations between dietary potassium intake and hyperkalemia in patients with chronic kidney disease (CKD). This study investigated the association between potassium intake from different food sources and hyperkalemia in patients with non-dialysis-dependent CKD. METHODS: A total of 285 patients were recruited at a university hospital and two city hospitals in Tokyo. Dietary potassium intake was estimated by a validated diet history questionnaire...
April 13, 2024: Journal of Renal Nutrition
https://read.qxmd.com/read/38621240/nephrology-what-you-may-have-missed-in-2023
#28
JOURNAL ARTICLE
Ali A M AlHabobi, Ashwaq M S Almutairi, Danah A S Y Bohemid, Ashwini R Sehgal
This article highlights a selection of important nephrology studies published in 2023 that have relevance for nonnephrologist physicians. Four studies examined progression of chronic kidney disease or cardiovascular disease with respect to finerenone use, magnesium supplementation, iron markers, and COVID-19. Two studies examined treatments to improve specific aspects of chronic kidney disease management, including daprodustat to address anemia and patiromer to address hyperphosphatemia. One study showed that acetazolamide added to loop diuretics increased diuresis in acute decompensated heart failure across a wide range of renal function...
April 16, 2024: Annals of Internal Medicine
https://read.qxmd.com/read/38619824/electronic-health-record-population-health-management-for-chronic-kidney-disease-care-a-cluster-randomized-clinical-trial
#29
JOURNAL ARTICLE
Manisha Jhamb, Melanie R Weltman, Susan M Devaraj, Linda-Marie Ustaris Lavenburg, Zhuoheng Han, Alaa A Alghwiri, Gary S Fischer, Bruce L Rollman, Thomas D Nolin, Jonathan G Yabes
IMPORTANCE: Large gaps in clinical care in patients with chronic kidney disease (CKD) lead to poor outcomes. OBJECTIVE: To compare the effectiveness of an electronic health record-based population health management intervention vs usual care for reducing CKD progression and improving evidence-based care in high-risk CKD. DESIGN, SETTING, AND PARTICIPANTS: The Kidney Coordinated Health Management Partnership (Kidney CHAMP) was a pragmatic cluster randomized clinical trial conducted between May 2019 and July 2022 in 101 primary care practices in Western Pennsylvania...
April 15, 2024: JAMA Internal Medicine
https://read.qxmd.com/read/38618923/case-based-discussion-of-the-acute-hepatic-porphyrias-updates-on-pathogenesis-diagnosis-and-management
#30
REVIEW
Manisha Balwani, Siobán Keel, Peter Meissner, Mark Sonderup, Penelope Stein, Makiko Yasuda
The acute hepatic porphyrias (AHPs) include three autosomal dominant disorders, acute intermittent porphyria, variegate porphyria  and hereditary coproporphyria, and the ultra-rare autosomal recessive 5-aminolevulinic acid dehydratase-deficient porphyria. All four are characterized by episodic acute neurovisceral attacks that can be life-threatening if left untreated. The attacks are precipitated by factors that induce hepatic 5-aminolevulinic acid synthase 1 (ALAS1), resulting in accumulation of the porphyrin precursors, 5-aminolevulinic acid and porphobilinogen, which are believed to cause neurotoxicity...
April 15, 2024: Liver International: Official Journal of the International Association for the Study of the Liver
https://read.qxmd.com/read/38618725/exploration-of-diagnostic-markers-associated-with-inflammation-in-chronic-kidney-disease-based-on-wgcna-and-machine-learning
#31
JOURNAL ARTICLE
Qianjia Wu, Yang Yang, Chongze Lin
Chronic kidney disease (CKD) is a common disorder related to inflammatory pathways; its effective management remains limited. This study aimed to use bioinformatics analysis to find diagnostic markers that might be therapeutic targets for CKD. CKD microarray datasets were screened from the GEO database and the differentially expressed genes (DEGs) in CKD dataset GSE98603 were analyzed. Gene set variation analysis (GSVA) was used to explore the activity scores of the inflammatory pathways and samples. Algorithms such as weighted gene co-expression network analysis (WGCNA) and Lasso were used to screen CKD diagnostic markers related to inflammation...
2024: Critical Reviews in Immunology
https://read.qxmd.com/read/38618503/capacity-for-the-management-of-kidney-failure-in-the-international-society-of-nephrology-north-america-and-the-caribbean-region-report-from-the-2023-isn-global-kidney-health-atlas-isn-gkha
#32
REVIEW
Racquel Lowe-Jones, Isabelle Ethier, Lori-Ann Fisher, Michelle M Y Wong, Stephanie Thompson, Georges Nakhoul, Shaifali Sandal, Rahul Chanchlani, Sara N Davison, Anukul Ghimire, Kailash Jindal, Mohamed A Osman, Parnian Riaz, Syed Saad, Stephen M Sozio, Somkanya Tungsanga, Alexandra Cambier, Silvia Arruebo, Aminu K Bello, Fergus J Caskey, Sandrine Damster, Jo-Ann Donner, Vivekanand Jha, David W Johnson, Adeera Levin, Charu Malik, Masaomi Nangaku, Ikechi G Okpechi, Marcello Tonelli, Feng Ye, Rulan S Parekh, Shuchi Anand
The International Society of Nephrology Global Kidney Health Atlas charts the availability and capacity of kidney care globally. In the North America and the Caribbean region, the Atlas can identify opportunities for kidney care improvement, particularly in Caribbean countries where structures for systematic data collection are lacking. In this third iteration, respondents from 12 of 18 countries from the region reported a 2-fold higher than global median prevalence of dialysis and transplantation, and a 3-fold higher than global median prevalence of dialysis centers...
April 2024: Kidney International Supplements
https://read.qxmd.com/read/38618502/capacity-for-the-management-of-kidney-failure-in-the-international-society-of-nephrology-western-europe-region-report-from-the-2023-isn-global-kidney-health-atlas-isn-gkha
#33
REVIEW
Maria Pippias, Gaetano Alfano, Dearbhla M Kelly, Maria Jose Soler, Letizia De Chiara, Timothy O Olanrewaju, Silvia Arruebo, Aminu K Bello, Fergus J Caskey, Sandrine Damster, Jo-Ann Donner, Vivekanand Jha, David W Johnson, Adeera Levin, Charu Malik, Masaomi Nangaku, Ikechi G Okpechi, Marcello Tonelli, Feng Ye, Rosanna Coppo, Liz Lightstone
Western Europe boasts advanced health care systems, robust kidney care guidelines, and a well-established health care workforce. Despite this, significant disparities in kidney replacement therapy incidence, prevalence, and transplant access exist. This paper presents the third International Society of Nephrology Global Kidney Health Atlas's findings on kidney care availability, accessibility, affordability, and quality in 22 Western European countries, representing 99% of the region's population. The known chronic kidney disease (CKD) prevalence across Western Europe averages 10...
April 2024: Kidney International Supplements
https://read.qxmd.com/read/38618501/capacity-for-the-management-of-kidney-failure-in-the-international-society-of-nephrology-north-and-east-asia-region-report-from-the-2023-isn-global-kidney-health-atlas-isn-gkha
#34
REVIEW
Winston Wing-Shing Fung, Hyeong Cheon Park, Yosuke Hirakawa, Silvia Arruebo, Aminu K Bello, Fergus J Caskey, Sandrine Damster, Jo-Ann Donner, Vivekanand Jha, David W Johnson, Adeera Levin, Charu Malik, Masaomi Nangaku, Ikechi G Okpechi, Marcello Tonelli, Seiji Ueda, Feng Ye, Yusuke Suzuki, Angela Yee-Moon Wang
Globally, there remain significant disparities in the capacity and quality of kidney care, as evidenced by the third edition of the International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA). In the ISN North and East Asia region, the chronic kidney disease (CKD) burden varied widely; Taiwan had the heaviest burden of treated kidney failure (3679 per million population [pmp]) followed by Japan and South Korea. Except in Hong Kong, hemodialysis (HD) was the main dialysis modality for all other countries in the region and was much higher than the global median prevalence...
April 2024: Kidney International Supplements
https://read.qxmd.com/read/38618500/capacity-for-the-management-of-kidney-failure-in-the-international-society-of-nephrology-latin-america-region-report-from-the-2023-isn-global-kidney-health-atlas-isn-gkha
#35
REVIEW
Viviane Calice-Silva, Javier A Neyra, Alejandro Ferreiro Fuentes, Krissia Kamile Singer Wallbach Massai, Silvia Arruebo, Aminu K Bello, Fergus J Caskey, Sandrine Damster, Jo-Ann Donner, Vivekanand Jha, David W Johnson, Adeera Levin, Charu Malik, Masaomi Nangaku, Ikechi G Okpechi, Marcello Tonelli, Feng Ye, Magdalena Madero, Carmen Tzanno Martins
Successful management of chronic kidney disease (CKD) in Latin America (LA) continues to represent a challenge due to high disease burden and geographic disparities and difficulties in terms of capacity, accessibility, equity, and quality of kidney failure care. Although LA has experienced significant social and economic progress over the past decades, there are still important inequities in health care access. Through this third iteration of the International Society of Nephrology Global Kidney Health Atlas, the indicators regarding kidney failure care in LA are updated...
April 2024: Kidney International Supplements
https://read.qxmd.com/read/38618499/capacity-for-the-management-of-kidney-failure-in-the-international-society-of-nephrology-eastern-and-central-europe-region-report-from-the-2023-isn-global-kidney-health-atlas-isn-gkha
#36
REVIEW
Caner Alparslan, Jolanta Malyszko, Fergus J Caskey, Mirna Aleckovic-Halilovic, Zdenka Hrušková, Silvia Arruebo, Aminu K Bello, Sandrine Damster, Jo-Ann Donner, Vivekanand Jha, David W Johnson, Adeera Levin, Charu Malik, Masaomi Nangaku, Ikechi G Okpechi, Marcello Tonelli, Feng Ye, Vladimir Tesar, Sanjin Racki
Delivery of care for kidney failure (KF) globally has a significant disparity; even in some countries, it means end of life for the person. The International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA) tries to address gaps in KF care and standardize global nephrology care. From the third iteration of the ISN-GKHA, we present data for countries in the ISN Eastern and Central Europe region. The median prevalences of chronic kidney disease (12.8%) and treated KF (873.5 pmp) were higher than the global rates, respectively...
April 2024: Kidney International Supplements
https://read.qxmd.com/read/38618498/capacity-for-the-management-of-kidney-failure-in-the-international-society-of-nephrology-middle-east-region-report-from-the-2023-isn-global-kidney-health-atlas-isn-gkha
#37
REVIEW
Sabine Karam, Atefeh Amouzegar, Iman Rashed Alshamsi, Saeed M G Al Ghamdi, Siddiq Anwar, Mohammad Ghnaimat, Bassam Saeed, Silvia Arruebo, Aminu K Bello, Fergus J Caskey, Sandrine Damster, Jo-Ann Donner, Vivekanand Jha, David W Johnson, Adeera Levin, Charu Malik, Masaomi Nangaku, Ikechi G Okpechi, Marcello Tonelli, Feng Ye, Ali K Abu-Alfa, Shokoufeh Savaj
The highest financial and symptom burdens and the lowest health-related quality-of-life scores are seen in people with kidney failure. A total of 11 countries in the International Society of Nephrology (ISN) Middle East region responded to the ISN-Global Kidney Health Atlas. The prevalence of chronic kidney disease (CKD) in the region ranged from 4.9% in Yemen to 12.2% in Lebanon, whereas prevalence of kidney failure treated with dialysis or transplantation ranged from 152 per million population (pmp) in the United Arab Emirates to 869 pmp in Kuwait...
April 2024: Kidney International Supplements
https://read.qxmd.com/read/38618497/capacity-for-the-management-of-kidney-failure-in-the-international-society-of-nephrology-oceania-and-south-east-asia-osea-region-report-from-the-2023-isn-global-kidney-health-atlas-isn-gkha
#38
REVIEW
Anna Francis, Marina Wainstein, Georgina Irish, Muhammad Iqbal Abdul Hafidz, Titi Chen, Yeoungjee Cho, Htay Htay, Talerngsak Kanjanabuch, Rowena Lalji, Brendon L Neuen, Emily See, Anim Shah, Brendan Smyth, Somkanya Tungsanga, Andrea Viecelli, Emily K Yeung, Silvia Arruebo, Aminu K Bello, Fergus J Caskey, Sandrine Damster, Jo-Ann Donner, Vivekanand Jha, David W Johnson, Adeera Levin, Charu Malik, Masaomi Nangaku, Ikechi G Okpechi, Marcello Tonelli, Feng Ye, Muh Geot Wong, Sunita Bavanandan
The International Society of Nephrology (ISN) region of Oceania and South East Asia (OSEA) is a mix of high- and low-income countries, with diversity in population demographics and densities. Three iterations of the ISN-Global Kidney Health Atlas (GKHA) have been conducted, aiming to deliver in-depth assessments of global kidney care across the spectrum from early detection of CKD to treatment of kidney failure. This paper reports the findings of the latest ISN-GKHA in relation to kidney-care capacity in the OSEA region...
April 2024: Kidney International Supplements
https://read.qxmd.com/read/38618496/capacity-for-the-management-of-kidney-failure-in-the-international-society-of-nephrology-newly-independent-states-and-russia-region-report-from-the-2023-isn-global-kidney-health-atlas-isn-gkha
#39
REVIEW
Larisa Prikhodina, Kirill Komissarov, Nikolay Bulanov, Silvia Arruebo, Aminu K Bello, Fergus J Caskey, Sandrine Damster, Jo-Ann Donner, Vivekanand Jha, David W Johnson, Adeera Levin, Charu Malik, Masaomi Nangaku, Ikechi G Okpechi, Marcello Tonelli, Feng Ye, Abduzhappar Gaipov
The International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA) was established to aid understanding of the status and capacity of countries to provide optimal kidney care worldwide. This report presents the current characteristics of kidney care in the ISN Newly Independent States (NIS) and Russia region. Although the median prevalence of chronic kidney disease (CKD) was higher (11.4%) than the global median (9.5%), the median CKD-related death rate (1.4%) and prevalence of treated kidney failure (KF) in the region (411 per million population [pmp]) were lower than they are globally (2...
April 2024: Kidney International Supplements
https://read.qxmd.com/read/38618495/capacity-for-the-management-of-kidney-failure-in-the-international-society-of-nephrology-south-asia-region-report-from-the-2023-isn-global-kidney-health-atlas-isn-gkha
#40
REVIEW
Eranga Wijewickrama, Muhammad Rafiqul Alam, Divya Bajpai, Smita Divyaveer, Arpana Iyengar, Vivek Kumar, Ahad Qayyum, Shankar Prasad Yadav, Manjusha Yadla, Silvia Arruebo, Aminu K Bello, Fergus J Caskey, Sandrine Damster, Jo-Ann Donner, Vivekanand Jha, David W Johnson, Adeera Levin, Charu Malik, Masaomi Nangaku, Ikechi G Okpechi, Marcello Tonelli, Feng Ye, Dibya Singh Shah, Narayan Prasad
The South Asia region is facing a high burden of chronic kidney disease (CKD) with limited health resources and low expenditure on health care. In addition to the burden of CKD and kidney failure from traditional risk factors, CKD of unknown etiologies from India and Sri Lanka compounds the challenges of optimal management of CKD in the region. From the third edition of the International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA), we present the status of CKD burden, infrastructure, funding, resources, and health care personnel using the World Health Organization's building blocks for health systems in the ISN South Asia region...
April 2024: Kidney International Supplements
keyword
keyword
19487
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.